METHOD FOR PROPHYLAXIS OF RELAPSE LITHIASIS

FIELD: medicine. ^ SUBSTANCE: method involves administration of hyaluronidase conjugate (lydazum) with activated derivative of poly-1,4-ethylenepiperazine N-oxide (analog of polyoxidonium) in a single dose 3000 IU by intramuscular route, 3 days before of operative removal of concrements. After remov...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	SKRJABIN GENNADIJ NIKOLAEVICH, TRUBNIKOVA KSENIJA EVGEN'EVNA, SAAD EHLIAS INAAM, BAREEVA ROZA SIBAGATOVNA, NAZAROV TOIRKHON KHAKNAZAROVICH, TIKTINSKIJ OLEG LEONIDOVICH, PASTUSHENKOV VLADIMIR LEONIDOVICH, KARPISHCHEKO ANATOLIJ IVANOVICH, ALEKSANDROV VALERIJ PAVLOVICH, MIKHAJLICHENKO VLADIMIR VASIL'EVICH
Format:	Patent
Sprache:	eng ; rus
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	FIELD: medicine. ^ SUBSTANCE: method involves administration of hyaluronidase conjugate (lydazum) with activated derivative of poly-1,4-ethylenepiperazine N-oxide (analog of polyoxidonium) in a single dose 3000 IU by intramuscular route, 3 days before of operative removal of concrements. After removal of concrements the drug is administrated in indicated dose by the following schedule - once for 3 days, 5 injections, then once for 5 days, 15 injections, then once for 10 days, 15 injections. Proposed invention provides improvement and normalization of physicochemical and biochemical indices of urine that promotes to decreasing of relapse lithiasis. ^ EFFECT: improved method of prophylaxis. ^ 1 tbl, 1 ex